Lisa Jarvis
- Indexed articles, last 90 days
- 18
- Latest publication
- Sep 17, 2026
- Outlet visibility, for seattletimes.com
- Top 50K sites
- Earliest in this view
- Jul 6, 2026
Latest articles
Healthcare costs have small businesses in an impossible bind (opens the original)
Read excerpt
The healthcare affordability crisis is crushing everyone, but it has become downright calamitous for small businesses. Survey after survey after survey shows that employers expect healthcare costs to rise nearly 10% on average in 2027, a figure that could be twice as high for small firms. Those businesses — a key driver of the U.S. economy — are running out of ways to make the math on healthcare coverage work. Many have been pushed to the breaking point. They need relief, and so do the millions
Healthcare costs have small businesses in an impossible bind (opens the original)
Read excerpt
The healthcare affordability crisis is crushing everyone, but it has become downright calamitous for small businesses. Survey after survey after survey shows that employers expect healthcare costs to rise nearly 10% on average in 2027, a figure that could be twice as high for small firms. Those businesses â a key driver of the U.S. economy â are running out of ways to make the math on healthcare coverage work. Many have been pushed to the breaking point. They need relief, and so do the milli
Healthcare costs have small businesses in an impossible bind (opens the original)
Read excerpt
This column reflects the personal views of the author and does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners. Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, healthcare and the pharmaceutical industry. Previously, she was executive editor of Chemical & Engineering News . The healthcare affordability crisis is crushing everyone, but it has become downright calamitous for small businesses. Survey after survey after survey shows that employ
The White House can't hype away healthcare sticker shock (opens the original)
Read excerpt
This column reflects the personal views of the author and does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners. Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Previously, she was executive editor of Chemical & Engineering News. Any genuine efforts to lower high U.S. prescription drug prices should be embraced. But President Donald Trump’s latest deal with drug manufacturers to lower those price
Extreme heat is making it harder for kids to learn (opens the original)
Read excerpt
This column reflects the personal views of the author and does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners. Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, healthcare and the pharmaceutical industry. Previously, she was executive editor of Chemical & Engineering News. Each year, schools around the country spend the last weeks of summer break preparing for the day when promising young minds flood through their doors. Yet educators and p
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For seattletimes.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.